Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - enoxaparin sodium -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 9500 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 7600 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 5700 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 3800 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 2850 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 1900 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - mivacurium chloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; water for injections - mivacron is a highly selective, non-depolarising neuromuscular blocking agent with a fast recovery profile and a short duration of action. mivacron is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation. this formulation contains no antimicrobial preservative and is intended for single patient use.